nzyme
The nzyme group focuses on the three fundamentals that enable full patient access – Education, Access & Activation. Our specialist practices help deliver innovation and expertise, to truly put customers at the heart of the approach, and all backed up by the advice and support of our independent ‘Brain’s Trust’ of industry experts.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Genesis Research Group
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Inizio
Welcome to Inizio. Your market-leading commercialization partner, providing tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Origins – The Patient Focused Specialists
Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value by involving patients throughout the entire product life cycle. We…
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups.
Red Thread Market Access Ltd
Blending brilliant writing with in-depth market access and reimbursement expertise
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Visions4Health
Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…
Company Details
Latest Content from PMHub
Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization
Press Releases | July 14, 2026 | Real Chemistry
The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of business growth and client value
Older trial participants reject bad design, not technology
White Papers and Resources | July 8, 2026 | Cuttsy + Cuttsy
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
White Papers and Resources | July 2, 2026 | Cuttsy + Cuttsy
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.
Press Releases | July 2, 2026 | Medscape Education
Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at...
Moving Beyond the 10%: A New Era in Preterm Birth Prevention
Press Releases | July 1, 2026 | Medscape Education
For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause...
It’s time to stop calling adverse events ‘manageable’
White Papers and Resources | June 29, 2026 | Cuttsy + Cuttsy
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
Supporting our team with an award-winning mental health strategy
Press Releases | June 26, 2026 | Mednet
Mental health has been at the centre of our business since our inception. But that work doesn't just extend to our client projects. Find out more about our award-winning mental...
The value: why localisation pays off across global trials
White Papers and Resources | June 26, 2026 | Cuttsy + Cuttsy
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
Genesis Research Group launches free access to EVID AI, its full-spectrum evidence synthesis platform, through 2026
Press Releases | June 24, 2026 | Genesis Research Group
Genesis Research Group today announced that its EVID AI evidence synthesis platform will be available free of charge through 2026 for approved life sciences organizations and eligible researchers. “Run it...
Medscape Education to Showcase the Impact of Neurology CME at EAN 2026
Press Releases | June 23, 2026 | Medscape Education
Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the upcoming 12th Congress of the European Academy of Neurology (EAN) 2026 in Geneva,...